WASHINGTON--In an alarming trend, top selling drugs are being pulled from pharmacies after researchers find new, and often fatal, side effects.
Since 1997, 11 popular prescription drugs have been recalled by the Food and Drug Administration (FDA) after causing deaths or serious injuries. Two weeks ago, Lotronex became the latest to be taken off the market for a reported intestinal side effect. It had been on the shelves for nine months.
Although the FDA, under congressional pressure, has sped up the approval process for new drugs, it is not willing to take all the blame. Officials with the administration say that doctors should be paying more attention. Too often doctors are ignoring, or just not reading warning labels.
Doctors counter that the FDA is not appropriately testing new drugs before releasing them to the public. Every medication is tested on a few hundred to a few thousand patients. There are 82 workers who track the side effects once these drugs reach the market. With such a small pool of test patients and researchers, the FDA often has to sit back and wait to see what side effects occur when millions of Americans start using a new prescription.
If a problem arises, the FDA tries to issue warnings, but they often go unheeded. For two years, the administration warned that heartburn drug Propulsid should not be prescribed to people with kidney or heart disease. However, the warning was ignored and the drug was taken off shelves last summer after a reported 80 people died.
The FDA and doctors agree that patients should ask more questions about new prescription drugs. Patients should also be cautious about taking drugs that have not been on the market for more than a year. Most side effects are spotted within the first year of sale.
Information from www.latimes.com
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.